Silo Pharma Inc (SILO) — Strategic Asset Allocation Index

Latest as of December 2017: 109.7%

Silo Pharma Inc (SILO) has a Strategic Asset Allocation Index of 109.7% as of December 2017. Strategic assets (PP&E of $- plus long-term investments of $1.32 Million) total $1.32 Million, measured against net assets of $1.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check SILO asset resilience ratio to evaluate the company's liquid asset resilience ratio.

SAAI

109.7%
Strategic Assets / Net Assets

Strategic Assets

$1.32 Million
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$1.20 Million
USD

Silo Pharma Inc Strategic Asset Allocation Index (2016–2017)

This chart shows how Silo Pharma Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2016 to 2017. As of December 2017, the index stands at 109.7%, representing strategic assets of $1.32 Million against net assets of $1.20 Million USD. See Silo Pharma Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Annual Strategic Asset Allocation Index for Silo Pharma Inc (2016–2017)

The table below presents the year-by-year Strategic Asset Allocation Index for Silo Pharma Inc from 2016 to 2017, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Silo Pharma Inc stock valuation.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2017 109.7% $1.32 Million $- $1.32 Million $1.20 Million ▲ +34.7 pp
2016 75.0% $634.87K $- $634.87K $846.51K
pp = percentage points